CEMI Chembio Diagnostics Inc
Market Cap
16.17M
Day’s Range
52W Range
Volume (3M)
563.62K
Price-Earnings Ratio
-
Revenue
59.75M
Chembio Diagnostics Inc Latest News



About Chembio Diagnostics Inc
Chembio is a healthcare firm that develops, manufactures, and commercializes point-of-care diagnostic tests which detect and diagnose diseases. Founded in 1985, the company has headquarters in Hauppauge, New York and operates within the US. Chembio is listed under the CEMI ticker on the NASDAQ CM stock exchange. Keep up-to-date with the latest price movements of the CEMI stock by adding it to your eToro watchlist.
Show More337
Employees
Hauppauge, New York, US
HQ
1985
Founded
Richard L. Eberly, MBA
CEO
Upcoming Earnings
2
MAR
REPORTS
Chembio Diagnostics Inc Q4 2022 earnings report is expected to be released after market open
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
39
Very Low
Industry
Avg. 50
32
Environment
40
Social
49
Governance
People Also Bought
- SFT Shift Technologies Inc Class A -11.92%
- COCP Cocrystal Pharma Inc -5.63%
- HEXO HEXO Corp -5.71%
- ATIP ATI Physical Therapy Inc -4.65%
- BHG Bright Health Group Inc. 1.11%